Welcome to the Working Group on New TB Drugs Blog
Posted in Faces of TB, TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Kick TB Campaign: Scoring Big in South Africa and Beyond
The Kick TB Campaign is a unique project that uses the World’s most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).
News from the TB Treatment Field
Recent articles from around the globe related to governments addressing problems with providing treatment services to those with tuberculosis
Posted in TB Patient Perspective, TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Video: Jenniffer Dietrich, Challenge Facility for Civil Society
Jenniffer Dietrich is Technical Officer at the Challenge Facility for Civil Society of the Stop TB Partnership.
Posted in Action, Announcements, TB Pediatrics, Video, Voices from the Fight to Stop Tuberculosis
Call to Action on Childhood TB
The Stop TB Partnership has issued a Call to Action on Childhood TB. The call was an outcome of an international meeting organized jointly by the European Centre for Disease Prevention and Control (ECDC) and the Stop TB Partnership’s Childhood TB Subgroup in March. There was strong consensus among participants on the urgent need to make the voice of children heard through concerted advocacy efforts. Links are provided to information on the Call to Action and to a page where you can sign the Call to Action on Childhood TB. There are also links to previous coverage by the WGND on topics related to Childhood TB.
Posted in Announcements, market access, TB News, TB Prevention and Control Strategies, TB Treatment, Video
Private TB Drug Market is Larger than Expected
The first detailed study of the private tuberculosis (TB) drug market, published on May 4th, in the PLoS ONE journal, finds that the market is surprisingly large, and has irregular practices that could be driving treatment failures and contributing to the emergence of multidrug-resistant TB (MDR-TB).
Looking Through the Eyes of the Patient
Each day, thousands of people around the world are affected by tuberculosis whether directly or indirectly, and every 20 seconds one of these people die. We present links to two stories about real people encountering, combating, and eventually overcoming TB in there personal lives.
The 2010 Working Group on New TB Drugs Annual Meeting
The 2010 WGND Annual Meeting will be held on Friday, November 12, 2010 in Berlin. Please check back here for continuously updated information.
This Week in TB – Report from Open Forum 4
While there were few new TB treatment prospects a few years ago, today there are 10 drugs in the global development pipeline. Noting the sea of change, Wednesday’s Open Forum conference focus shifted from developing drugs to speeding them through development and to the patients that need them.
Viewpoint: We Need New TB Drugs – Part Two
Last week, Dr. Kaiser shared his thoughts and perspectives as a medical doctor on the current state of TB drug regimens. This week he shares specific ideas on how TB drug R&D could be improved.
Viewpoint: We Need New TB Drugs – Part One
Antibiotics are, to the typical patient, always the quick fix. Despite our best attempts to convince them that their viral bronchitis will get better without that course of amoxicillin, anyone who has worked a primary care clinic knows the pressure to throw antibiotics at the problem, even when we ourselves know it’s not the answer, because our patients perceive it as the fast track to health. A couple weeks, they reason, and the infection is over. Normalcy ought to resume. Then you tell them they have tuberculosis, and “normalcy” is at least six months away, if everything goes according to plan. And tuberculosis is a wily enough contender to make sure everything won’t.
-
Toppix TB News- Editorial: Lives at risk if the U.S. shortchanges Global Fund 4 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- WHO says TB in Russia displays highest known drug resistance 3 Feb 2012
- Media outlets examine Global Fund's future as it enters second decade 3 Feb 2012
